- Home
- BLW vs EBS Comparison
BLW vs EBS Comparison
Compare BLW & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLW
- EBS
- Stock Information
- Founded
- BLW 2003
- EBS 1998
- Country
- BLW United States
- EBS United States
- Employees
- BLW N/A
- EBS N/A
- Industry
- BLW Other Consumer Services
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- BLW Consumer Discretionary
- EBS Health Care
- Exchange
- BLW Nasdaq
- EBS Nasdaq
- Market Cap
- BLW 513.9M
- EBS 459.6M
- IPO Year
- BLW N/A
- EBS 2006
- Fundamental
- Price
- BLW $14.14
- EBS $9.40
- Analyst Decision
- BLW
- EBS Strong Buy
- Analyst Count
- BLW 0
- EBS 2
- Target Price
- BLW N/A
- EBS $14.00
- AVG Volume (30 Days)
- BLW 85.9K
- EBS 1.6M
- Earning Date
- BLW 01-01-0001
- EBS 11-06-2024
- Dividend Yield
- BLW 8.83%
- EBS N/A
- EPS Growth
- BLW N/A
- EBS N/A
- EPS
- BLW 1.81
- EBS N/A
- Revenue
- BLW N/A
- EBS $1,125,500,000.00
- Revenue This Year
- BLW N/A
- EBS $7.98
- Revenue Next Year
- BLW N/A
- EBS $6.62
- P/E Ratio
- BLW $7.73
- EBS N/A
- Revenue Growth
- BLW N/A
- EBS 2.05
- 52 Week Low
- BLW $12.35
- EBS $1.42
- 52 Week High
- BLW $14.26
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- BLW 42.74
- EBS 50.73
- Support Level
- BLW $14.00
- EBS $8.12
- Resistance Level
- BLW $14.37
- EBS $12.68
- Average True Range (ATR)
- BLW 0.13
- EBS 0.91
- MACD
- BLW -0.01
- EBS -0.18
- Stochastic Oscillator
- BLW 27.45
- EBS 33.67
About BLW Blackrock Limited Duration Income Trust
Blackrock Ltd Duration Income Trust is a diversified investment fund with an investment objective to provide current income and capital appreciation. The Fund's portfolio normally has an average portfolio duration of less than five years. The Fund may invest directly in such securities or synthetically through the use of derivatives.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.